Change over period
From:
To:
Zoom:
- 1Y
- 3Y
- 5Y
- 10Y
- 15Y
- 20Y
- Max
Embecta Corp
NASDAQ EMBC
Data sourced from
and
and
Embecta Corp Net Operating Profit After Tax (NOPAT) for the Trailing 12 Months (TTM) ending March 31, 2024: 239,373,737.37
Embecta Corp Net Operating Profit After Tax (NOPAT) is 239,373,737.37 for the Trailing 12 Months (TTM) ending March 31, 2024, a 356.85% change year over year. Net Operating Profit After Taxes (NOPAT) is a financial metric that represents a company's operating profit after deducting taxes. It is calculated by multiplying the earnings before interest and taxes (EBIT) by (1 - tax rate). NOPAT provides insights into the company's profitability from its core operations while accounting for the impact of taxes. It is useful for assessing the company's operating performance and comparing profitability across different tax environments.
-
Embecta Corp Net Operating Profit After Tax (NOPAT) for the Trailing 12 Months (TTM) ending March 31, 2023 was 52,397,028.59, a -48.18% change year over year.
-
Embecta Corp Net Operating Profit After Tax (NOPAT) for the Trailing 12 Months (TTM) ending March 31, 2022 was 101,109,448.69, a -4.77% change year over year.
-
Embecta Corp Net Operating Profit After Tax (NOPAT) for the Trailing 12 Months (TTM) ending March 31, 2021 was 106,179,136.69.
Don’t Miss A Beat
Looking to stay ahead of the competition and stay informed? Receive your daily dose of market news, trends, and analysis to kickstart your day and stay up-to-date.
NASDAQ: EMBC
| CEO | Mr. Devdatt Kurdikar |
| IPO Date | April 1, 2022 |
| Location | United States |
| Headquarters | 300 Kimball Drive, Parsippany, NJ, United States, 07054 |
| Employees | 2,200 |
| Sector | Healthcare |
| Industry | Medical instruments & supplies |
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Key trends
Similar companies
AngioDynamics Inc
NA
NA
Akoya Biosciences Inc
NA
NA
StockViz Staff
September 19, 2024
Any question? Send us an email